Multi-peptide serum This is a general term for a cosmetic serum containing more than one peptide ingredient or more than one complex containing peptides. Although the name seems simple, it does not describe a standardized formulation.
There is no universally accepted number of peptides that a product must contain in order to be classified as a „peptidic”. The name itself does not also inform about the concentration of the peptides, the type of vehicle, the delivery system, stability, or the expected clinical effect.
Therefore, two products sold as a multi-peptide serum can differ significantly from each other. They may contain different peptide sequences, different chemical modifications, different excipients, and other concentrations. They may also have been evaluated using completely different types of studies.
From a scientific point of view, the most important question therefore does not simply read: How many peptides are there in the serum?
The question is much more useful whether there is relevant evidence regarding ready-made formulation, which confirm the specific declared effect.
Published studies include, among others, randomized controlled serum peptide studies, open-label multi-product skincare regimens, laboratory experiments regarding formulations and penetration, and studies in which products containing peptides were used in conjunction with professional treatments.
Each of these research projects answers a different question. Therefore, the results should not be used to make a general conclusion that serums containing a higher number of peptides automatically work better.
The evaluation of a multi-peptide product requires a closer look. the identity of the ingredients, information that can be obtained from the INCI list, the properties of the formulation, data regarding delivery and stability, and the quality of the studies on the finished product.
What exactly does „multi-peptide” mean?
The word „multi” simply means more than one. It does not inform about which peptides are present in the product, how much of each of them was used, or whether they were tested together.
One formulation may contain several precisely defined synthetic peptides. Another may use one or more commercial peptide complexes composed of multiple components. Still another may contain hydrolyzed protein, in which many different peptide fragments are present.
All these products can be broadly defined as containing many peptides, but chemically and analytically they are completely different systems.
This is also important when interpreting the names of the ingredients.
tripeptide means a single peptide chain composed of three amino acid residues, whereas heksapeptide consists of six amino acid residues.
This does not mean that the product contains three or six separate peptides accordingly.
Similarly, the number appearing after the name of a cosmetic peptide does not necessarily indicate the number of peptides contained in the bottle.
A correct understanding of this terminology allows us to avoid confusing chemical names with marketing „peptides lists”.
Why is the exact identity of the peptide important?
When evaluating claims regarding a cosmetic product, the ready formulation remains the most important unit.
A controlled clinical study involving a specific peptide preparation does not prove that any serum containing a different peptide sequence will yield the same result.
For example, studies concerning palmitoylpentapeptide they evaluate this specific material under specific formulation and exposure conditions. [1]
They do not automatically confirm the activity of each pentapeptide, each peptide subjected to palmitoylation, or each multi-peptide cosmetic containing an entirely different combination of ingredients.
Peptides can also be chemically modified.
The molecule can be acetylated, combined with a fatty acid group, cyclized, or modified in other ways. The chemical name can therefore convey more information than just the number of amino acids in the chain.
Randomized clinical study regarding serum containing Cyclized hexapeptide-9 It well illustrates the importance of this distinction. [2]
The researchers evaluated a specific modified peptide formulation compared to specific control preparations.
The results therefore refer to the materials and formulations that were actually tested.
It should not be automatically transferred to an unmodified peptide, a different concentration, a different substrate, or an entirely different multipeptide mixture.
Peptide categories are not evidence of clinical efficacy
In the cosmetic literature, peptides are often divided into broad categories, such as signaling peptides, carrier peptides, or peptides that are believed to have an effect on processes related to neurotransmission.
Such classifications can be useful when discussing proposed biological mechanisms.
However, they do not prove that every peptide belonging to a given category reaches the intended target in human skin in an amount sufficient to elicit the expected effect.
Laboratory testing can support the biological plausibility of a particular mechanism. Controlled human testing, however, can provide information about a visible or measurable clinical effect.
Combining these two levels of evidence requires additional data.
The peptide must have the correct identity, maintain proper stability, be delivered by a formulation, and be evaluated in a study to verify the proposed relationship.
The cosmetic product can therefore improve a specific parameter of the skin's appearance without proving all the molecular mechanisms used to explain this effect.
Multipeptide serum does not automatically mean copper peptides
Serum containing several peptides does not have to contain a copper peptide complex.
On the other hand, a product containing copper peptide may have many other ingredients and a completely different evidence base than a multi-peptide preparation without copper.
Definition „The ”multi-peptide” does not allow determining whether copper is present in the product..
The actual list of ingredients must be checked.
This is especially important when interpreting information regarding the combination of cosmetics or their compatibility.
Limitations, interactions, or study results regarding a single metal-binding peptide complex should not be automatically applied to all products labeled as multipeptide.
The chemistry of the specific ingredients and the instructions for the finished product provide much more information than the category name alone.
What can be determined based on the list of ingredients?
The INCI list can help identify many ingredients intentionally added to formulations.
The names of peptides, humectants, solvents, emollients, preservatives, and other substances can be found on it.
However, the list of ingredients usually does not reveal the full production recipe, the detailed stability profile, or the amount of peptide that reaches the specific part of the skin after application.
The presence of a component and the proven delivery of it to a specific location are two different matters.
The name of the peptide on the label confirms its declared presence in the product, but it does not itself specify the exact concentration, bioavailability, penetration, or clinical efficacy.
Additional evidence is needed to answer these questions.
How to interpret the percentages of peptide complexes?
Percentual statements regarding peptide complexes require careful interpretation.
If the manufacturer states that the serum contains a certain percentage „peptid complex”, This value can refer to the entire raw material supplied, not to the amount of pure peptide.
A commercial complex may contain the peptide along with water, solvents, stabilizers, carriers, or other components.
Therefore, a product containing a specific percentage of one peptide complex cannot be automatically compared with a product providing a different percentage.
Both values can describe completely different quantities.
Before comparing such statements, it is necessary to establish What exactly the given percentage refers to.
A similar problem occurs with the information about the number of peptides placed on the front of the packaging.
One manufacturer can count the named peptide ingredients separately. Another can count entire commercial complexes. A third can include peptides along with other proprietary „technologies” into one larger marketing package.
If the manufacturer does not explain in detail how the calculation is made, such values should not be considered an equivalent measure of the complexity or „power” of the product.
Does the INCI order allow determining the concentration of the peptide?
The order of the components provides some information, but does not allow the exact concentration of the peptide to be calculated.
According to Article 19 of the EU Cosmetics Regulation, ingredients are essentially listed in descending order by mass at the time of addition to the product. However, ingredients present in concentrations below 1% may be listed in any order after the ingredients present in concentrations above 1%. [3]
This has important practical consequences.
A peptide found at the end of the INCI list cannot be automatically considered to be present in a lower concentration than any component listed directly before it.
It is also not possible to reliably determine the order of concentrations of several components present at low levels solely based on their position.
At the same time, a low concentration does not automatically mean that it is ineffective.
In a controlled study, palmitoylethanolamide was evaluated in a preparation containing the peptide in a relatively low concentration. [1]
This does not mean that every product with a low concentration of peptide is effective.
It shows, however, why the concentration should be interpreted together with the the identity of the component, the formulation, the exposure, and the evidence regarding the specific product.
It also works in the other direction.
A high position on the list or an impressive percentage on the packaging are not in themselves a proof of a clinically significant effect.
Which popular ingredients are not peptides?
The marketing of multi-ingredient cosmetics can sometimes blur the differences between peptides and the accompanying substances.
Hyaluronic acid is not a peptide. Niacinamide is not a peptide. Free amino acids are not automatically peptide chains. Gamma-aminobutyric acid, or GABA, is also not a peptide only because it is present in the formulation alongside the peptides.
This is important when counting the actual number of peptides in the product.
An open-label study evaluated serum containing GABA along with several peptides and additional skincare products.[4]
This was an example of a complex, multi-component intervention.
However, it would not be chemically correct to treat each distinguished component as another peptide or to attribute the observed changes solely to the number of peptides.
Auxiliary ingredients can also significantly affect the effectiveness of cosmetics.
The serum may increase hydration in part through humectants or the properties of the substrate, rather than because all the observed changes result from the action of peptides.
Therefore, when analyzing such products, it can be helpful to have a separate understanding of the related dependencies. peptides and hyaluronic acid and peptides and niacinamide.
This does not diminish the value of the formulated formulation. It only allows for more accurate attribution of the observed effects.
Defined peptides and peptide hydrolysates are not the same thing
Hydrolyzed contains fragments formed during the breakdown of larger proteins or peptide materials.
On the other hand, a defined synthetic peptide has a specific amino acid sequence.
These materials therefore differ in composition and the method of their analytical characterization.
A study performed with an exactly defined synthetic peptide does not automatically confirm the action of a mixture of hydrolyzed protein.
Similarly, results regarding the hydrolizate should not be automatically transferred to a precisely defined synthetic peptide.
Therefore, the information that the product contains „many peptides”, It remains incomplete without knowledge of the identity and characteristics of the peptide material.
The theoretical presence of numerous fragments is not in itself a clinical result.
The most important question still remains: what Has the formulated formulation applied to the skin actually been shown in studies to be effective?
Why is the serum base important?
The basis of the formulation this is the environment where the peptides and other components are located.
It can affect the distribution of the product, the release of ingredients, stability, and interaction with the skin.
The peptide does not function independently of that environment only because its name is included in the INCI list.
Experimental studies comparing acetyl hexapeptide-8 in different emulsion systems showed differences in the delivery of the peptide in a pig skin model. [5]
This proves that the structure of the formulation can influence the delivery of the component.
However, it does not prove that serums containing more peptides penetrate the skin better.
It also does not show that a more expensive product must provide a larger portion of its peptide ingredients.
In another study, the penetration of acetyl hexapeptide-8 from a cosmetic emulsion was measured using human cadaveric and animal skin. Under experimental conditions, penetration to deeper areas was limited.[6]
It should not be assumed on that basis that no peptide can ever penetrate the skin.
The experiment, however, shows that the proposed biological target and experimentally confirmed exposure are two separate issues.
Claims regarding penetration should therefore be based on measurements for a specific peptide and a specific formulation.
Stability is just as important as the number of peptides
The cosmetic product should retain its proper properties for the intended period of storage and use.
The integrity of peptides, physical stability, and microbiological quality are related but separate issues.
The product may look completely normal, but this does not prove the chemical integrity of each peptide.
Similarly, confirmation of peptide stability does not automatically mean correct microbiological quality or clinical efficacy.
Studies of prepared formulations containing acetyl hexapeptide-8 used analytical, physical and release testing methods.[7]
In other studies, an analytical method was developed to study the degradation of a peptide in skin homogenates.[8]
These experiments cover various environments and answer different questions.
They cannot be replaced by a simple calculation of the peptides in the list of ingredients.
A serum containing many peptides can be a very well-developed formulation.
A simpler product with one or two peptides can also be stable and exhibit a specific cosmetic effect.
The sheer number of ingredients does not prove the superiority of any of them.
More about the importance of temperature, light, packaging and storage conditions can be read in a separate article about them. Storage of peptides.
Does a higher concentration of peptides mean better results?
The relationship between concentration and clinical effect must be determined for a specific peptide and formulation.
Increasing the amount of the ingredient may change the formulation properties, skin exposure, or tolerance, but it does not necessarily lead to a proportional increase in the cosmetic effect.
Therefore, it should not be assumed that a twice higher concentration means a twice higher effect.
Comparing two different serums also does not allow the influence of peptide concentration to be isolated if the products differ in terms of the substrate, additional ingredients, and the identity of the peptides.
The same principle applies when comparing a peptide serum with another category of cosmetics.
The study comparing specific peptide serums with retinol at a specific concentration evaluated the preparations used in this study specifically. For example, the study of cyclized hexapeptide-9 used specific comparative preparations. [2]
This does not mean that the peptide formulation under study is better than all retinol products, equivalent to them or able to replace them.
A broader discussion of these differences can be found in the article peptides and retinol.
Does the combination of several peptides lead to synergy?
Two peptides may have different proposed biological mechanisms, which could provide a rational basis for studying them together.
However Rational combination is not the same as proven synergy.
Even if the multipeptide formulation yields a statistically significant result, this does not automatically indicate a synergistic interaction between its peptides.
Synergy means something more concrete than the presence of several ingredients in a single product.
An appropriate study could compare the substrate itself, peptide A, peptide B, and the combination of A+B, with the appropriate matching of the remaining components.
Such a project would allow testing the additional contribution of the combination and the possibility of the occurrence of interactions.
Comparing the entire product without the use of the substance answers a much broader question.
Therefore, the word „synergy” should not simply be a more attractive term for „contains several peptides”.
What do controlled studies of multipeptide serum show?
In a randomized, double-blind, placebo-controlled clinical study, serum peptides targeted at mimic lines were evaluated in patients with facial paralysis. 55 women for 12 weeks. [9]
Researchers noted favorable results regarding the evaluation of mimic lines compared to placebo.
Randomization, blinding, and the use of a placebo make the study provide more controlled information about this specific serum than ordinary user opinions or uncontrolled „before and after” photos.
However, Nadal does not show that he was responsible for the difference. number of peptides.
It also does not allow for the independent contribution of each peptide present in the formulation to be determined.
The evidence therefore relates to the tested serum under specific conditions, rather than the general principle that a higher number of peptides means better results.
What do open-label studies of multi-product regimens say?
In a 14-week study involving 29 women peptid serum was evaluated along with additional skincare products. [4]
During the study, the participants and the researchers reported improvements.
The open nature of the study and the use of several products simultaneously lead to uncertainty regarding the contribution of each component and the individual stages of care.
Expectations, the simultaneous use of other cosmetics, and natural changes that occur over time can also influence the results of observation.
This does not mean that the study is worthless.
It, however, limits the scope of the requests.
It can be concluded that beneficial changes were observed during the use of the tested regimen.
However, it cannot be determined that one specific peptide was responsible for it, the total number of peptides, or a specific interaction between them.
Studies of multicomponent formulations require careful attribution of effects
In a four-week randomized pilot study, serum containing Niacinamide, postbiotics and peptides in 25 healthy participants [10]
The result regarding hydration should be considered separately from the results regarding transcutaneous water loss, i.e. TEWL.
According to the published information, no significant difference was observed between the groups in terms of TEWL despite the result regarding hydration. [10]
This example shows two important issues.
First of all, because several categories of components were combined in one formulation, it is not easy to attribute the observed effect specifically to the peptides.
Secondly, improvements in hydration should not be automatically translated into a broader claim that every parameter of the skin barrier has improved.
Marketing statements such as „rebuilds the skin barrier” it can therefore be significantly wider than the actual endpoint measured.
Multipeptide serum studied together with treatments
Some studies on peptide serums were conducted in conjunction with professional treatments, rather than as part of regular home care.
In the 2026 split-face study involving 54 participants Injections of recombinant collagen with a locally applied multi-peptide serum were compared with injections of collagen alone. [11]
The study therefore concerned the effect of adding serum in a specific therapeutic context.
It did not compare the multi-peptide serum with the base during ordinary home care.
It also did not compare products containing different numbers of peptides.
Another study evaluated serum containing a tripeptide and a hexapeptide in combination with laser resurfacing. [12]
Such studies can provide valuable information about the use of supportive therapy, but the therapeutic context must remain clearly indicated.
They do not prove that consumers should independently perform such procedures at home.
They also do not confirm the validity of injecting cosmetic serum, home microdermabrasion using it, or the assumption that the results obtained in combination with the treatment will also appear during regular topical application.
The differences between the local application, injection, and other routes of exposure are discussed in more detail in the article about injections of peptides and other routes of administration.
Adjust the statement to the appropriate measurement
Different cosmetic claims require different evidence.
The claim that the product moistens, It requires proper measurement of moisture or evaluation of sensations.
The claim that reduces the visibility of wrinkles, It requires appropriate visual, clinical or instrumental evaluation.
The claim that increases the amount of collagen, It requires evidence relating specifically to such a biological change.
Whereas the claim that serum It works better because it contains more peptides, This requires a study that allows the effect of the number of peptides to be separated from all other differences between the products.
The broader the claim, the more evidence is needed to justify it.
The consumer satisfaction survey does not indicate penetration through the skin.
The cell study does not confirm the apparent clinical effect in humans.
Similarly, the term „clinically examined” It only says that a certain form of clinical trial is being announced.
It does not inform whether the study was randomized, blinded, controlled, appropriately sized, or independently replicated.
It is the methods and results that determine the actual evidentiary value.
How to interpret percentages and statistical results?
The percentage reduction given in the study may describe different magnitudes.
It can mean an average change across the entire group, a change in the result of an instrumental measurement, or the percentage of participants reaching a previously defined threshold.
These are not exchange values.
Without knowledge of exactly what was measured and what comparator was used, an impressive percentage value may be difficult to interpret properly.
Statistical significance also does not automatically indicate how large, visible, or practically significant the difference was.
The more informative description includes the magnitude of the effect, its variability or uncertainty, the comparator used, and the observation time.
If researchers evaluated many parameters, the results that remain unchanged or are statistically insignificant should also remain visible, instead of presenting only beneficial results.
Funding and the quality of the research are also important
Commercial involvement does not automatically mean that the study is unreliable.
Funding, the author's relationship with the producer, the choice of comparator, the method of analysis, and reporting practices are, however, important when assessing the strength of the evidence.
Independent replication of results and transparent reporting can increase trust in results.
An abstract may suffice to describe the general design of the study and the most important results, but it often does not contain all the details needed for a full assessment of the risk of systematic error.
If such information is lacking, the uncertainty should be clearly indicated.
A positive conclusion in the abstract should not be taken as evidence that blinding was ideal, that all participants followed the protocol, that the statistical analysis was optimal, or that adverse events were comprehensively reported.
Does the study concern the current version of the product?
The next important question is whether the published study concerned exactly that ready-made formulation that is currently being discussed.
The study could have included the entire product, the individual peptide component of the supplier, an earlier version of the recipe, or another form of the product.
The manufacturer's materials can help you find the study, but they should not replace the analysis of the original source.
Cosmetics can also be reformulated while maintaining the known name.
Similarly, studies of creams, patches, or formulations used during the procedure do not automatically confirm the effectiveness of the serum.
Studies of a single peptide do not confirm all products containing a peptide with a similar name.
Matching the researched intervention is therefore more useful than matching a broad marketing term.
More ingredients do not automatically mean a greater number of proofs
A longer list of ingredients creates more possible interactions and proposed mechanisms.
However, it does not automatically lead to a greater number of confirmed clinical effects.
In many cases, the most scientifically precise statement is relatively simple:
The specific formulated formulation improved a specific parameter in a specific population, at a specific time and under the conditions applied in the study.
It sounds less spectacular than the claim that a complex peptide mixture affects all signs of skin aging.
From a scientific point of view, however, it provides much more useful information.
However, if the question concerns the practical use of such a product in skincare, the application points, the layering of the product, or the frequency of use, these issues are discussed in more detail in the article. How to use the peptide serum.
Frequently asked questions about the multi-peptide serum
Do all multipeptide serums contain the same peptides?
No. The term „multi-peptide” does not mean a single common combination of peptides, concentrations, vehicle, or auxiliary ingredients. In published studies, various peptide serums and multi-product skincare regimens were evaluated, and the results remain consistent with the formulations actually being studied. [4][9] Two products can therefore have a very similar category name while significantly differing in composition and available evidence.
Does serum containing more peptides work better automatically?
No. The number of peptides is not a clinical endpoint or a commonly accepted measure of a cosmetic product’s „strength.” Experimental studies show that the delivery of the same peptide can vary with the change in the formulation’s base material. [5] To prove that the number of peptides alone increases the product’s efficacy, a study designed specifically to isolate this factor would be needed.
Does „heksapeptide” mean that the product contains six peptides?
No. Hexapeptide is a single peptide chain composed of six amino acid residues. Acetyl hexapeptide-8 is an example of the name of a specific peptide component, not a mixture of six or eight separate peptides. [6] The chemical nomenclature and the numbers of peptides listed on the package describe different things.
Are amino acids, GABA, niacinamide and hyaluronic acid also peptides?
No. Free amino acids are not automatically peptide chains; GABA, niacinamide, and hyaluronic acid are chemically different substances. In a published study of the care regimen, GABA and several peptides were described as separate components.[4] Counting each designated component as a separate peptide therefore leads to a misrepresentation of the formulation.
Does the peptide at the end of the INCI list mean that it cannot work?
Such a conclusion cannot be drawn solely from the position of the ingredient. EU rules regarding the order of ingredients allow for greater flexibility in the case of substances below a specified concentration threshold, and controlled studies have also evaluated preparations containing peptides at relatively low concentrations.[1][3] This does not prove the efficacy of a particular cosmetic, but it shows why the specific position on the INCI list is insufficient in itself.
Does a higher percentage of the peptide complex mean more pure peptide?
Not necessarily. The percentage given may refer to the entire complex containing the peptide along with the solvents, carriers, or other components. If the manufacturer does not specify exactly what the percentage refers to, direct comparison of the two products can be misleading. [7]
Do all multipeptide serums contain copper peptides?
No. The term „multi-peptide” does not indicate whether the product contains a copper complex. It is necessary to check the actual list of ingredients. Evidence, limitations, or information regarding a specific copper peptide should not be automatically applied to all multi-peptide serums.
Is a serum with a single peptide automatically worse than a multi-peptide one?
No. A product does not need to contain many peptides to be clinically evaluated. In controlled studies, for example, preparations containing a specific palmitoilopentapeptide were analyzed.[1] This does not prove the superiority of any single-ingredient product, but it does show that the number of peptides is not a prerequisite for conducting studies or a confirmed predictor of better results.
Do laboratory studies prove that a multi-peptide serum will improve the appearance of the skin?
No. The response observed in cells or other experimental model and the clinical effect seen in humans represent different levels of evidence. Laboratory studies may support a specific hypothesis regarding the mechanism, but to determine whether the formulated formulation causes the declared change visible on the skin, appropriate human studies are needed.[2]
Does more peptides mean better penetration through the skin?
Not necessarily. The delivery of peptides depends, among other things, on the properties of the molecule and the formulation, and not only on the number of peptide components. Experimental comparisons of different emulsion systems have shown differences in the delivery of the same peptide. [5] This does not prove that adding additional peptides increases penetration.
Does the combination of several peptides automatically mean synergy?
No. The combination may yield a beneficial result without demonstrating a synergistic interaction. Studies of multicomponent formulations often do not allow determining the independent contribution of each component. [4][10] Confirmation of synergy requires a design that allows the comparison of the individual components with their combination.
Does the improvement in hydration mean that the multi-peptide serum has restored the skin barrier?
Not automatically. Hydration and skin barrier parameters are different endpoints. In a niacinamide pilot study, postbiotics and peptides yielded different results regarding hydration and TEWL. [10] The product can provide a useful moisturizing effect without confirming all aspects of structural or functional barrier repair.
Does the study of the multi-peptide serum used in conjunction with injections prove that it will work the same at home?
No. The study related to the procedure evaluates the combined clinical intervention. In the split-face study, the topical serum was used in conjunction with recombinant collagen injections and compared with the injections alone. [11] This was not a study of the routine use of the serum in home conditions. The treatment context and other elements of the intervention are part of the study and should not be overlooked when interpreting the results.
Does the term „clinically tested” mean strong evidence?
Not in itself. The term does not specify whether the study was randomized, blinded, placebo-controlled, appropriately large, or independently replicated. Randomized product-controlled studies and open-label studies of the entire routine may include people, but they provide a different level of control over alternative explanations. [4][9] What matters are the actual methods, the number of participants, the comparator, disclosed conflicts of interest, and the possibility of repeating the results.
Does a multi-peptide serum irritate the skin more because it contains more ingredients?
The number of peptides alone does not determine greater or lesser risk of irritation. Tolerance depends on the specific ingredients, their concentrations, the formulation matrix, exposure conditions, and the population being studied. Results regarding tolerance from one study apply to a specific product, not to all serums containing a similar number of peptides.[9]
Does the degradation study of a peptide determine the shelf life of the product?
No. The peptide degradation study and the stability study of the finished cosmetic correspond to different questions. Experiments using skin homogenates analyze degradation in an environment containing enzymes, whereas formulation studies assess the properties of the prepared substrates. [7][8] Defining the shelf life requires data relating to the actual packaged product and the intended storage conditions.
How best to determine whether one multipeptide serum is better than the other?
The most informative would be well-designed Direct clinical study of both finished products, Using previously defined endpoints, appropriate comparative preparations, and transparent reporting of tolerability. Separate beneficial studies of two products do not allow for a reliable determination of superiority if they differ in the participant population, formulation, application schedule, and measured results. [2][9] The conclusion should therefore be based on the actually conducted comparison, and not on the number of peptides, percentages on the package, price, or marketing terminology.
Summary
Definition Multipeptide serum describes a formulation concept, not a standardized product, concentration or potency scale..
Products designated in this way can significantly differ in peptide identity, chemical modifications, concentration, formulation base, excipients, stability, and method of delivery.
Even the way peptides or peptide complexes are counted can vary between manufacturers, which makes simple comparisons of the numbers on the packaging misleading.
That is why The number of peptides in serum is usually less informative than the quality of the evidence regarding the finished formulation..
The list of ingredients helps determine what is in the product, but it does not itself specify the exact concentration of the peptides, their stability, penetration, or clinical effectiveness.
Similarly, a high percentage of a peptide complex does not necessarily mean an equally high concentration of pure peptide if the manufacturer does not explain exactly what this value refers to.
The formulation basis also matters. Experimental studies show that a change in the delivery system can affect the transport of the peptide, and penetration studies remind us why the mere presence of a peptide on the label should not be equated with proven delivery to the proposed biological target.[5][6]
Clinical evidence also needs to be interpreted in accordance with the study design. Randomized controlled trials can provide stronger information about a specific formulation than uncontrolled observations, but even a well-conducted study of a finished product does not necessarily indicate which individual peptide was responsible for the observed effect.
Open-label studies of multi-product regimens can document beneficial changes, leaving uncertainty regarding their cause; however, studies related to professional procedures should remain interpreted within the context of these procedures.
Claims regarding moisturizing, wrinkle appearance, collagen, penetration, skin barrier function, and synergy They also require different types of evidence.
Improvements in one parameter should not automatically be transformed into a claim about improvements in all the other parameters.
Ultimately, a reliable assessment of the multi-peptide serum should combine the current ready-made formulation with a clearly defined result evaluated in an appropriately designed study, At the same time, it points out that available evidence does not allow conclusions to be drawn about individual components, the number of peptides, mechanisms, synergies, or the possibility of transferring the results to other products.
A product containing many peptides can be useful for a specific cosmetic effect. A simpler formulation can also work well.
However, none of these conclusions can be drawn solely based on the number of peptides.
Disclaimer
This article is purely educational and scientifically informative. Its purpose is to explain the terminology related to cosmetic peptides, the interpretation of ingredient lists, formulation issues, and the method of evaluating research on multi-peptide serums.
The text does not promote or recommend a specific cosmetic product, does not present an individual skincare regimen, does not constitute medical or dermatological advice, and does not suggest that peptide serum can diagnose, prevent, or treat diseases.
Studies involving a specific peptide, peptide complex, serum, formulation, concentration, or professional treatment should not be automatically considered evidence regarding other products that use similar marketing terminology.
The results of laboratory models, formulation studies, open treatment regimens, controlled clinical trials, and studies related to treatments should remain linked to the conditions in which they were obtained.
Individual skin reactions may vary. Persistent or aggravated redness, swelling, irritation, or other concerning reactions may require appropriate evaluation by a qualified specialist.
References
- Robinson, L. R., Fitzgerald, N. C., Doughty, D. G., Dawes, N. C., Berge, C. A., & Bissett, D. L. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 155–160. https://doi.org/10.1111/j.1467-2494.2005.00261.x
- Chang, H., Tao, K., Yang, Y., Wang, Y., Ge, M., Wang, X., Tang, S., & Yu, H. (2025). Novel cyclized hexapeptide-9 outperforms retinol against skin aging: A randomized, double-blinded, active- and vehicle-controlled clinical trial. Journal of Cosmetic Dermatology, 24(7), Article e70290. https://doi.org/10.1111/jocd.70290
- European Parliament & Council of the European Union. (2009). Regulation (EC) No 1223/2009 on cosmetic products, Article 19. Retrieved September 25, 2026, from https://eur-lex.europa.eu/eli/reg/2009/1223/oj/eng
- Draelos, Z. D., Kononov, T., & Fox, T. (2016). An open label clinical trial of a peptide treatment serum and supporting regimen designed to improve the appearance of aging facial skin. Journal of Drugs in Dermatology, 15(9), 1100–1106. https://pubmed.ncbi.nlm.nih.gov/27602972/
- Hoppel, M., Reznicek, G., Kählig, H., Kotisch, H., Resch, G. P., & Valenta, C. (2015). Topical delivery of acetyl hexapeptide-8 from different emulsions: Influence of emulsion composition and internal structure. European Journal of Pharmaceutical Sciences, 68, 27–35. https://doi.org/10.1016/j.ejps.2014.12.006
- Kraeling, M. E., Zhou, W., Wang, P., & Ogunsola, O. A. (2015). In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutaneous and Ocular Toxicology, 34(1), 46–52. https://doi.org/10.3109/15569527.2014.894521
- Ruiz, M. A., Clares, B., Morales, M. E., Cazalla, S., & Gallardo, V. (2007). Preparation and stability of cosmetic formulations with an anti-aging peptide. Journal of Cosmetic Science, 58(2), 157–171. https://pubmed.ncbi.nlm.nih.gov/17520155/
- Errante, F., Menicatti, M., Pallecchi, M., Giovannelli, L., Papini, A. M., Rovero, P., & Bartolucci, G. (2021). Susceptibility of cosmeceutical peptides to proteases activity: Development of dermal stability test by LC-MS/MS analysis. Journal of Pharmaceutical and Biomedical Analysis, 194, Article 113775. https://doi.org/10.1016/j.jpba.2020.113775
- Nguyen, T. Q., Zahr, A. S., Kononov, T., & Ablon, G. (2021). A randomized, double-blind, placebo-controlled clinical study investigating the efficacy and tolerability of a peptide serum targeting expression lines. Journal of Clinical and Aesthetic Dermatology, 14(5), 14–21. https://pubmed.ncbi.nlm.nih.gov/34188744/
- Rusic, D., Ivic, M., Slugan, A., Leskur, D., Modun, D., Durdov, T., Vukovic, D., Bukic, J., Bozic, J., & Seselja Perisin, A. (2024). Pilot study on the effects of a cosmetic serum containing niacinamide, postbiotics, and peptides on facial skin in healthy participants: A randomized controlled trial. Life, 14(12), Article 1677. https://doi.org/10.3390/life14121677
- Qin, X., Zhai, J., Liu, L., Shu, H., Zhu, L., Shi, Q., & Luo, Y. (2026). Effectiveness and safety of recombinant type III humanized collagen solution injection combined with collagen-III multi-peptide serum in improving signs of photoaging: A prospective, split-face controlled clinical trial. Journal of Cosmetic Dermatology, 25(5), Article e70857. https://doi.org/10.1111/jocd.70857
- Wang, J. V., Christman, M. P., Feng, H., Ferzli, G., Jeon, H., & Geronemus, R. G. (2020). Topical tripeptide and hexapeptide treatment as adjunct to nonablative fractional resurfacing for photodamage: A randomized split-face trial. Journal of Cosmetic Dermatology, 19(12), 3245–3250. https://doi.org/10.1111/jocd.13795